Tech Leaders, AI Innovators Underscore Importance of AI Safety Institute Ahead of Committee Consideration of Cantwell-Young Future of AI Innovation Act

Leading tech organizations, companies and safety policy advocates from across the artificial intelligence (AI) community wrote Commerce Committee leaders today urging passage of the Cantwell-Young Future of AI Innovation Act that would codify the U.S. Artificial Intelligence Safety Institute (AISI) at the National Institute of Standards and Technology (NIST).

Cantwell Statement on FTC Action Into Concerning Surveillance Pricing, Calls for Comprehensive Privacy Law

U.S. Senator Maria Cantwell (D-Wash.), Chair of the Senate Committee on Commerce, Science and Transportation, released the following statement yesterday after the Federal Trade Commission (FTC) issued orders to eight companies requesting information about their products and services that use personal data to set individual prices for consumers. The orders seek information about the potential impact these practices have on privacy and consumer protection:

Experts Warn Senators AI is Upping the Urgency for Federal Privacy Law

U.S. Senator Maria Cantwell (D-Wash.), Chair of the Senate Committee on Commerce, Science and Transportation, convened a hearing this morning with legal, policy and private sector privacy and artificial intelligence (AI) experts to explore how the rapid advancement of AI is accelerating the urgency to pass a federal privacy law.

Cantwell, Blackburn, Heinrich Introduce Legislation to Increase Transparency, Combat AI Deepfakes & Put Journalists, Artists & Songwriters Back in Control of Their Content

Today, U.S. Senators Maria Cantwell (D-Wash.), Chair of the Senate Commerce Committee, Marsha Blackburn (R-Tenn.), member of the Commerce Committee, and Martin Heinrich (D-N.M.), member of the Senate AI Working Group, introduced the Content Origin Protection and Integrity from Edited and Deepfaked Media Act (COPIED ACT), to combat the rise of harmful deepfakes.

Cantwell Urges Congress to Act on PBMs, As New FTC Report Reveals Prescription Drug Middlemen are Inflating Drug Costs

Today, the Federal Trade Commission (FTC) released an interim report showing that prescription drug middlemen are profiting at the expense of patients, inflating drug costs and squeezing local pharmacies. After reviewing the report, U.S. Senator Maria Cantwell (D-Wash.), Chair of the Senate Committee on Commerce, Science and Transportation, urged her colleagues to pass her bipartisan Pharmacy Benefit Manager Transparency Act that would hold these middlemen accountable.

On Senate Floor, Cantwell Calls on Colleagues to Regulate Prescription Drug Middlemen

Yesterday, U.S. Senator Maria Cantwell (D-Wash.), Chair of the Senate Committee on Commerce, Science and Transportation, called on her colleagues to pass her bipartisan legislation with Sen. Chuck Grassley (R-Iowa), the Pharmacy Benefit Manager Transparency Act, which would hold middlemen in the prescription drug market accountable for deceptive and unfair practices that drive up drug costs for consumers and force pharmacies out of business.